Smart blood test guides treatment for stubborn hodgkin lymphoma
Disease control
Not yet recruiting
This study tests a combination of the immunotherapy drug pembrolizumab and three chemotherapy drugs (GVD) in 38 adults whose Hodgkin lymphoma returned or did not respond to one prior treatment. A special blood test (ctDNA) is used to see how well the treatment is working and to g…
Phase: PHASE2 • Sponsor: Michael Spinner, MD • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC